$NUS

NU SKIN ENTERPRISES Q2 2026 Earnings Preview: Recent $NUS Insider Trading, Hedge Fund Activity, and More

Nu Skin Enterprises (NUS) is set to report Q2 2026 earnings on Aug. 10 after market close, according to Finnhub. Analysts expect revenue of $348.652M and EPS of $0.20. The article cites Q1 2026 revenue of $320.6M, down 12.04% YoY, plus recent insider sales and institutional 13F changes.

Original reporting
Published Aug 8, 2026, 9:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 6:43 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NU SKIN ENTERPRISES Q2 2026 Earnings Preview: Recent $NUS Insider Trading, Hedge Fund Activity, and More — source image
Decision brief

The 30-second read

$NUSNeutralMed
01

Why it matters

For NUS, the main tradable element is the scheduled Aug 10 after-hours earnings event and the consensus revenue and EPS figures cited. The insider and hedge-fund activity are secondary context, not a new fundamental catalyst.

02

Market read

Traders can use the consensus revenue ($348.652M) and EPS ($0.20) and the Aug 10 after-hours timing to plan earnings-risk exposure for NUS.

03

What to watch

The article does not discuss guidance, margins, or segment trends, so traders should focus on what management reports on Aug 10 rather than the positioning data alone.

Relevance 5/10Novelty 4/10Timing: ahead of Aug 10 after-market-close earnings release

Background

The piece frames NU Skin Enterprises’ upcoming Q2 2026 earnings release and summarizes recent insider sales and institutional holdings changes.

Company-level read

Ticker impact

$NUSNeutralMedium confidence
Context

NU Skin Enterprises is scheduled to report Q2 2026 earnings Aug 10 after the close, with consensus revenue of $348.652M and EPS of $0.20.

Expected impact

Near-term volatility is likely around the Aug 10 after-hours earnings release versus the $348.652M revenue and $0.20 EPS expectations.

Evidence & confidence

The article provides the earnings timing and consensus numbers, but it does not include a new company-specific fundamental update beyond insider sales and institutional position changes.

Market effects

Limited sector read-through because the article is primarily a single-name earnings preview plus trading-flow data.

No clear regional spillover described.

No global macro or cross-border catalyst mentioned.

Counterpoint

Insider sales and mixed 13F flows may be routine and not predictive of the earnings outcome; the only actionable driver here is the earnings print versus consensus.

Key entities

  • NU Skin Enterprises

    Subject of the earnings preview, scheduled to report Q2 2026 results on Aug 10 after market close.

  • Edwina D Woodbury

    Named insider who sold 7,203 shares of NUS in the past 6 months per the article.

  • James M Winett

    Named insider who sold 7,203 shares of NUS in the past 6 months per the article.

Related articles

$WHRMed

Whirlpool Q2 Earnings Call Highlights

Whirlpool (NYSE:WHR) reported Q2 earnings call updates. North America industry demand fell 3.4% YoY, but Whirlpool said it held market share. The company raised promotional pricing by over 10% in late April and expects further margin improvement in Q3. It targets $150M cost reductions in 2026, including $60M automation, and guided FY revenue up ~1.5% and FCF of ~$300M.

$WATMedAI 8/10

Waters Q2 Earnings Call Highlights

Waters (NYSE:WAT) reported Q2 updates from its earnings call. Materials Science Division revenue rose to $87M. Biosciences and Diagnostic Solutions acquired from BD generated $817M revenue. Waters raised FY organic constant-currency growth outlook to 7% to 9%, projecting FY reported revenue of $3.370B to $3.431B and adjusted EPS of $14.45 to $14.65.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$WMedAI 8/10

Wayfair Q2 Earnings Call Highlights

Wayfair (NYSE:W) said Q2 new-order growth accelerated for a fourth straight quarter to a post-COVID high, citing U.S. gains from pricing, selection, delivery speed and availability, plus initiatives like Wayfair Rewards and stores. Q3 revenue growth is forecast at high-single digits. Perigold sales grew over 35% YoY and exceeded $400M annual. Q2 gross margin was 30.0%, adjusted EBITDA $242M, and free cash flow $301M. The company issued $400M notes to redeem 2028 converts.

$VYXMed

NCR Voyix Q2 Earnings Call Highlights

NCR Voyix (NYSE:VYX) reported Q2 progress on enterprise platform transformations, including a remote Voyix POS installation for a large European grocery retailer completed in about half the usual time. Retail signed 40+ customers; retail revenue fell 20% to $365M due to hardware transition, but adjusted EBITDA rose 20% to $97M. Restaurant revenue fell 23% to $158M. Non-GAAP EPS was $0.17. Full-year 2026 outlook maintained: revenue $2.188B-$2.303B, adj EBITDA $432M-$447M, EPS $0.89-$0.92.

$VOYAMed

Voya Financial Q2 Earnings Call Highlights

Voya Financial (NYSE:VOYA) reported Q2 adjusted operating earnings of $190M for Retirement, with defined-contribution net inflows of $8.1B. Retirement fee revenue rose 10% and margins were 38%. Investment Management adjusted operating earnings rose 12% to $57M. Employee Benefits adjusted operating earnings were $22M in Q2. Voya repurchased $150M of stock in Q2.